This inventor holds 1 USPTO granted patent. Top assignee: Cmpd Licensing, LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Gus Bassani
Gus Bassani is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment of type-2 diabetes and weight management.
Latest Patents
Gus Bassani holds a patent for a method titled "Topical administration of GLP-1 receptor agonists." This innovative approach involves administering a pharmaceutically effective amount of a topical composition that includes a GLP-1 receptor agonist suspended in an anhydrous suspension base vehicle. The method is designed for oral absorption within the oral cavity, providing a new avenue for treating conditions related to type-2 diabetes, chronic weight maintenance, or overindulgence. The topical composition is specifically formulated to create a self-emulsifying liposome in the aqueous environment of the oral cavity.
Career Highlights
Gus Bassani is currently associated with Cmpd Licensing, LLC, where he continues to develop and refine his innovative ideas. His work has the potential to impact many lives by providing new treatment options for individuals struggling with diabetes and weight management.
Collaborations
Some of his notable coworkers include Daniel Banov and Jay Richard Ray, II. Their collaboration contributes to the innovative environment at Cmpd Licensing, LLC.
Conclusion
Gus Bassani's work exemplifies the spirit of innovation in the medical field. His patent for the topical administration of GLP-1 receptor agonists showcases his commitment to improving health outcomes for individuals with type-2 diabetes and related conditions. His contributions are a testament to the importance of innovation in addressing pressing health challenges.